Net Sales at Rs 1,509.42 crore in December 2025 up 19.3% from Rs. 1,265.19 crore in December 2024. Quarterly Net Profit at Rs. 175.08 crore in December 2025 up 205.71% from Rs. 57.27 crore in December ...

Net Sales at Rs 1,778.29 crore in December 2025 up 25.67% from Rs. 1,415.05 crore in December 2024. Quarterly Net Profit at Rs. 251.66 crore in December 2025 up 172.65% from Rs. 92.30 crore in ...

Laurus Labs' Q3 net profit soars to ₹252 crore with a 26% revenue increase, driven by strong generics and CDMO demand.

Laurus Labs Ltd (BOM:540222) reports robust financial results with significant growth in its generic division and strategic investments in advanced therapies.

In its investor presentation, Laurus Labs said that they are well on track to deliver healthy operational growth for financial year 2026.

Laurus Labs Q3 FY26: Revenue Up 30% YoY, Margins Expand to 26.1% 📈 | MCap 54,914.21 Cr - 9M FY26 revenue: ₹5,001 Cr, up 30% ...

Laurus Labs posted a manifold increase in net profit to ₹252 crore in the third quarter ended December 31, 2025, compared to ₹92 crore in the corresponding quarter of the previous financial year on ...

Laurus Labs reported a significant 174% surge in net profit to ₹252 crore in Q3, driven by robust generic business and high demand in CDMO small molecule offerings.

Laurus Labs Ltd. on Friday posted a remarkable surge in net profit for the first nine months of FY26, driven by strong momentum in its Generics and CDMO businesses.

Laurus Labs is back in focus as the latest research update resets the stock's price target, putting fresh attention on what is driving the changing narrative around the company. With no prior target ...

Market corrections often punish expensive stocks, but some hold firm. Mint explains why select high-valuation companies stay resilient, backed by earnings visibility, structural tailwinds, and ...

Find all the latest Q3 results 2026 updates of JSW Steel, Shriram Finance, Bharat Petroleum Corporation, Adani Green Energy ...